跳至主要内容
临床试验/NCT00282594
NCT00282594已完成不适用

No Outcome Benefit for the Use of Intensive Insulin Therapy in the Critically Ill General and Vascular Surgical Patient. A Randomized Prospective Trial.

Genesys2 个研究点 分布在 1 个国家目标入组 317 人开始时间: 2003年7月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
317
试验地点
2
主要终点
Mortality

研究概览

简要总结

We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.

详细描述

While evidence exists for using tight glycemic control in the critically ill cardiac surgical patient, other patient populations have yet to be studied. We performed a prospective randomized trial for using intensive insulin therapy in the general and vascular critically ill surgical patient population. We will compare tight glycemic control versus conventional glycemic control to determine if there is a benefit to the normalization of blood glucose levels in this patient population

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing a general or vascular surgical procedure requiring admission to the surgical intensive care unit as a result of ventilatory requirement, vasopressor support, or physiologic instability

排除标准

  • Under age 18

结局指标

主要结局

Mortality

次要结局

  • Length of ICU Stay
  • Ventilatory Requirement
  • Vasopressor Support
  • Incidence of Renal Failure
  • Incidence of Wound Infection

研究者

发起方
Genesys
申办方类型
Other

研究点 (2)

Loading locations...

相似试验